Floatz logo

L-GLUTAMIC ACID, 4-(3-FLUOROPROPYL)-, (4S)-

Stage IIIB Fallopian Tube Cancer

Vanderbilt-Ingram Cancer CenterSmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

73 Active assets in the Stage IIIB Fallopian Tube Cancer cohort.

Asset / SponsorPhaseRating
Carboplatin
Women's Hospital School Of Medicine Zhejiang University
Phase 3BBB
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 3BB
TAMOXIFEN
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 3BB
Cyclophosphamide
Mayo Clinic
Phase 2BB
Pembrolizumab
Roswell Park Cancer Institute
Phase 2BB

View all 50 →

Same molecule, other indications

L-GLUTAMIC ACID, 4-(3-FLUOROPROPYL)-, (4S)- is also rated in:

fallopian tube cancerDormant
C
Indicative ·
39 / 100
View asset →
ovarian cancerDormant
C
Indicative ·
39 / 100
View asset →
primary peritoneal carcinomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →